Arno Therapeutics, Inc
Arno Therapeutics, Inc (ARNI) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 89 transactions totaling $3.0M, demonstrating a bullish sentiment with $3.0M in net insider flow. The most recent transaction on Dec 30, 2016 involved a sale of 4,285,111 shares valued at $0.
ARNI Insider Activity Summary
Who Is Buying ARNI Stock?
No significant insider buying has been recorded for ARNI in the recent period.
Who Is Selling ARNI Stock?
No significant insider selling has been recorded for ARNI in the recent period.
Is Arno Therapeutics, Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARNI is bullish with an Insider Alignment Score of 100/100 and a net flow of $3.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ARNI Frequently Asked Questions
Understanding ARNI Insider Activity
Insider trading at Arno Therapeutics, Inc (ARNI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading ARNI stock, having executed 89 transactions in the past 90 days. The most active insider is Steven B. Ruchefsky (Executive), who has made 7 transactions totaling $2.5M.
Related Tools
Track Arno Therapeutics, Inc Insider Activity
Get notified when executives and directors at ARNI file new Form 4 transactions